Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SO vs MRNA✓SelectedUSD · MRNASO vs MRNA performance historyLatest closeAs of+0.87%11/18
Stock and ETF performance explorer

SO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+173.6%
MRNA return
+794.5%
Excess return
-620.9%
Maximum drawdown
-38.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.9%-4.8%+5.7%+0.9%
7D+1.4%-20.9%+22.3%+1.6%
30D+6.6%-13.3%+19.9%+6.7%
3M+3.4%+212.6%-209.2%+1.3%
6M+2.4%+309.0%-306.6%-0.2%
YTD+11.8%+567.3%-555.5%+7.7%
1Y+7.5%+689.7%-682.2%+3.2%
3Y+49.8%+157.4%-107.7%+45.5%
5Y+83.5%-21.7%+105.2%+81.5%
All+173.6%+794.5%-620.9%+144.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling